UPF0502 proteins are part of a larger family of uncharacterized proteins. These proteins are often identified through genomic sequencing but have not been extensively studied, meaning their functions and roles in biological systems are not well understood.
Uncharacterized proteins, such as those belonging to the UPF0502 family, are typically identified by their presence in genomic data but lack detailed functional annotations. They may be involved in various cellular processes, but without specific research, their exact roles remain speculative.
One of the significant challenges in studying uncharacterized proteins like VPA1223 is the lack of available data. Researchers often rely on bioinformatics tools and comparative genomics to predict potential functions, but experimental validation is necessary to confirm these hypotheses.
While specific applications for VPA1223 are not documented, uncharacterized proteins can sometimes offer novel targets for drug development or biotechnological innovations once their functions are elucidated.
| Category | Description |
|---|---|
| Identification | Identified through genomic sequencing. |
| Function | Generally unknown, requiring further research. |
| Potential Applications | Could be novel targets for drug development or biotechnology. |
| Research Challenges | Lack of functional annotations and experimental data. |
Lifeome: UPF0502 protein VPA1 - This source provides some general information on UPF0502 proteins but does not specifically address VPA1223.
Dissertation on Vibrio parahaemolyticus - While not directly related to VPA1223, it highlights the challenges and methodologies in studying microbial proteins.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in your order notes. We will accommodate your request whenever possible.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its inclusion.
Recombinant UPF0502 protein VPA1223 can be expressed in multiple host systems, each offering distinct advantages. For most research applications requiring high yields and rapid turnaround times, E. coli and yeast expression systems demonstrate superior performance . These prokaryotic and lower eukaryotic systems are particularly advantageous when basic structural studies or preliminary functional assays are the primary research objectives. The choice between these two systems should consider factors such as codon optimization, protein solubility requirements, and downstream purification strategies.
When studying VPA1223 in contexts where native-like post-translational modifications are crucial to protein folding or activity, expression in insect cells (via baculovirus vectors) or mammalian cell lines is recommended . These systems provide the cellular machinery necessary for appropriate glycosylation, phosphorylation, and other modifications that may be essential for proper protein folding or retention of biological activity. Researchers should conduct preliminary expression trials across multiple systems when investigating structure-function relationships that might be influenced by post-translational modifications.
Purification of VPA1223 typically follows standard recombinant protein workflows, but should be optimized based on expression system and experimental requirements. A multi-step purification strategy incorporating affinity chromatography (typically using His-tag or GST-tag systems depending on construct design) followed by size exclusion chromatography generally yields preparations of >95% homogeneity. For applications requiring exceptional purity, additional ion exchange chromatography steps may be integrated into the workflow, with careful consideration of the protein's isoelectric point and stability under various buffer conditions.
Mass spectrometry (MS) analysis of VPA1223 and its interaction partners requires careful experimental design. Similar to approaches used with prolamin proteins in databases like ProPepper, researchers should begin by performing in silico digestions with multiple proteolytic enzymes to identify optimal digestion strategies . For VPA1223, the conventional trypsin-based workflow may not yield optimal peptide coverage, and alternative enzymes should be considered. The peptide sequences generated through in silico digestion should be analyzed for uniqueness and specificity, especially when studying VPA1223 in complex biological samples.
Integration of database searching with software tools that incorporate peptide-matching algorithms is essential for proper identification. When designing MS-based experiments, researchers should:
Determine the optimal enzyme or multi-enzyme digestion strategy
Identify peptide markers specific to VPA1223
Optimize LC-MS parameters for detection of these marker peptides
Establish quantification methods using either label-free or isotope-labeled approaches
Given the UPF0502 (Uncharacterized Protein Family 0502) designation, predictive computational approaches are particularly valuable for elucidating potential functional domains. Researchers should implement a multi-algorithm approach combining homology modeling, ab initio structure prediction, and machine learning algorithms that incorporate evolutionary conservation data. Sequence alignment with better-characterized members of the protein family across diverse species provides insights into conserved regions likely to be functionally significant.
Domain prediction should integrate data from multiple sources, including secondary structure predictions, disorder predictions, and ligand-binding site analysis. For VPA1223 specifically, attention should be directed to regions showing high conservation across bacterial species, as these often correspond to functional motifs. Molecular dynamics simulations can further refine structural predictions, especially for regions with ambiguous folding patterns.
A factorial experimental design approach is recommended to efficiently identify optimal expression conditions. Key variables to test include:
| Variable | Range to Test | Optimization Metrics |
|---|---|---|
| Induction temperature | 16°C, 25°C, 37°C | Total yield, solubility |
| Inducer concentration | 0.1-1.0 mM IPTG (E. coli) | Expression level, aggregation |
| Induction duration | 4h, 8h, overnight | Protein integrity, yield |
| Media composition | Standard, enriched, minimal | Cost-efficiency, yield |
| Co-expression with chaperones | DnaK/J, GroEL/ES, trigger factor | Solubility, folding |
For each condition, assess both total protein expression and soluble fraction yield. Implement small-scale expression trials (50-100 mL cultures) before scaling to production volumes. SDS-PAGE and western blot analysis should be performed at each optimization step, with special attention to potential degradation products or truncated species.
Assessment of VPA1223 structural integrity should employ multiple complementary biophysical techniques:
Circular Dichroism (CD) spectroscopy to evaluate secondary structure content and thermal stability
Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) to determine oligomeric state and homogeneity
Differential Scanning Fluorimetry (DSF) to assess thermal stability under varying buffer conditions
Limited proteolysis to identify stable domains and flexible regions
These analyses should be conducted on freshly purified protein and repeated after various storage conditions to evaluate stability over time. For research requiring absolute confirmation of structural integrity, nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography may be necessary, though these approaches require significant time and resource investment.
Processing mass spectrometry data for VPA1223 identification requires careful consideration of database selection and search parameters. As demonstrated with databases like ProPepper for prolamin proteins, the specificity of the database can significantly impact peptide matching results . For VPA1223, researchers should:
Use protein databases that include comprehensive prokaryotic sequences
Consider creating custom databases with known VPA1223 variants when studying specific strains
Optimize search parameters based on the digestion enzymes used
Implement appropriate false discovery rate (FDR) thresholds (typically 1% at the protein level)
When peptide masses are identified, cross-reference them against theoretical digests to confirm specificity. For example, a peptide with a specific mass (e.g., 1000.4847 Da) should be evaluated for uniqueness to VPA1223 versus potential matches to other proteins . The table below illustrates how you might evaluate peptide specificity:
| Peptide Sequence | Origin Uniqueness | Enzymatic Method | Detection Confidence |
|---|---|---|---|
| XXXQPQXXXF | Unique to VPA1223 | Trypsin | High |
| PXXFQXXXQ | Present in VPA1223 and homologs | Chymotrypsin | Medium |
| QXXXQXXXF | Common sequence motif | Proteinase K | Low |
When analyzing protein-protein interaction data involving VPA1223, implement robust statistical approaches that account for both false positives and false negatives. For affinity purification-mass spectrometry (AP-MS) data, significance analysis of interactome (SAINT) or comparative proteomic analysis software (CompPASS) algorithms provide more reliable results than simple fold-change calculations.
For large datasets, implement multiple testing corrections (e.g., Benjamini-Hochberg) to control false discovery rates. Network analysis should employ both unsupervised clustering approaches (to identify novel interaction modules) and supervised analysis incorporating prior knowledge from protein interaction databases. When reporting interaction partners, clearly distinguish between high-confidence (reproducible across multiple experimental replicates) and candidate interactions requiring further validation.
Protein aggregation during VPA1223 expression often indicates folding challenges. Systematic troubleshooting approaches include:
Reducing expression temperature to 16-20°C to slow translation and facilitate proper folding
Co-expressing molecular chaperones that assist protein folding
Adding solubility-enhancing tags (SUMO, MBP, or TRX) to the expression construct
Including low concentrations (0.1-0.5%) of mild detergents or stabilizing agents in lysis buffers
Exploring refolding protocols if inclusion bodies persist
Each modification should be evaluated through small-scale expression trials before implementation at research scale. Document soluble protein yield through quantitative western blotting or activity assays rather than total protein expression.
When encountering variable digestion efficiency in proteomic analysis, implement a multi-enzyme strategy similar to that used in the ProPepper database for prolamin proteins . This approach increases sequence coverage and confidence in protein identification. Consider the following optimization steps:
Perform denaturation with multiple agents (urea, guanidine-HCl, or heat) to ensure complete protein unfolding
Implement extended reduction and alkylation steps to fully modify cysteine residues
Test enzyme combinations (e.g., trypsin followed by chymotrypsin) to generate complementary peptide sets
Include internal peptide standards to normalize for digestion efficiency across experiments
Document the peptide recovery for each digestion condition, noting sequence position and chemical characteristics. This creates a reliable protocol for consistent digestion results across experimental batches.
Recent advances in structural biology techniques hold particular promise for characterizing UPF0502 family proteins like VPA1223. Cryo-electron microscopy (cryo-EM) has dramatically improved resolution capabilities for proteins of varying sizes and now represents a viable alternative to X-ray crystallography, especially for proteins resistant to crystallization. Additionally, integrative structural biology approaches combining multiple data sources (small-angle X-ray scattering, crosslinking mass spectrometry, and computational modeling) provide complementary structural insights.
For VPA1223 specifically, AlphaFold2 and similar AI-based structure prediction tools have revolutionized the ability to generate reliable structural models even without experimental data. Researchers should consider implementing these computational predictions as starting hypotheses for experimental validation through targeted mutagenesis or ligand binding studies.
Systems biology approaches offer powerful frameworks for elucidating the functional context of poorly characterized proteins like VPA1223. Research strategies should include:
Comparative genomic analysis across species to identify conserved genetic neighborhoods
Co-expression network analysis to identify genes with correlated expression patterns
Metabolic profiling comparing wild-type and VPA1223 knockout/knockdown systems
Transcriptomic response to environmental perturbations in the presence/absence of VPA1223
These multi-omic approaches can generate testable hypotheses about VPA1223 function even in the absence of direct biochemical characterization. Integration of these datasets through machine learning approaches can further refine functional predictions and guide focused experimental designs.